U.S. District Court Upholds Validity of Lilly’s Alimta Patent Through 2022

U.S. District Court Upholds Validity of Lilly’s Alimta Patent Through 2022

[PR Newswire] – INDIANAPOLIS, March 31, 2014 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the Southern District of Indiana has ruled in the company’s favor regarding … more

View todays social media effects on LLY

View the latest stocks trending across Twitter. Click to view dashboard

See who Eli is hiring next, click here to view

Share this post